{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:14Z","timestamp":1753891934096,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Theophylline was an orally administered xanthine used for treatment of apnea of prematurity and Bronchopulmonary Dysplasia in ambulatory follow-up of Low-Birth-Weight infants (LBWI) with oxygen-dependency in the outpatient Kangaroo Mother Care Program (KMCP). Theophylline's main metabolic product is caffeine; therefore, it was an alternative due to the frequent lack of ambulatory oral caffeine in low and middle-income countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the effectiveness of oral theophylline in decreasing days with oxygen and to describe frequency of adverse related events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Quasi-experiment before and after withdrawal of theophylline given systematically to LBWI with ambulatory oxygen in two KMCPs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>729 patients were recruited; period 1: 319 infants when theophylline was given routinely and period 2: 410 infants when theophylline was no longer used. The theophylline cohort had less gestational age, less weight at birth, more days in Neonatal Intensive Care Unit, more days of oxygen-dependency at KMCP admission, and more frequencies of Intrauterine Growth Restriction and apneas. After adjusting with propensity score matching, multiple linear regression showed that nutrition was associated with days of oxygen-dependency, but theophylline treatment not. No differences were found in frequencies of readmissions up to 40 weeks, intraventricular hemorrhage or neurodevelopmental problems. Participants in period 2 had more tachycardia episodes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We did not find association between oral theophylline treatment and the reduction of days with ambulatory oxygen. For the current management of oxygen-dependency in LBW infants, the importance of nutrition based on exclusive breast feeding whenever possible, is the challenge.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1344291","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:08:05Z","timestamp":1724130485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Theophylline impact on weaning in oxygen-dependent infants followed in an outpatient Kangaroo Program"],"prefix":"10.3389","volume":"12","author":[{"given":"Adriana","family":"Montealegre-Pomar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Charpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Lince-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/jp.2012.6","article-title":"Altitude, oxygen and the definition of bronchopulmonary dysplasia","volume":"32","author":"Britton","year":"2012","journal-title":"J Perinatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7705\/biomedica.v34i1.1463","article-title":"Epidemia de displasia broncopulmonar: incidencia y factores asociados en una cohorte de ni\u00f1os prematuros en Bogot\u00e1, Colombia","volume":"34","author":"Ruiz-Pel\u00e1ez","year":"2014","journal-title":". Biom\u00e9dica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1590\/S0124-00642012000100009","article-title":"Curso cl\u00ednico y pron\u00f3stico a un a\u00f1o de una cohorte de pre maturos dados de alta con ox\u00edgeno domiciliario en Bogot\u00e1, Colombia","volume":"14","author":"Charpak","year":"2012","journal-title":". Revista de Salud Publica"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/ppul.25288","article-title":"Anemia, nutrition, and ambulatory oxygen weaning in a cohort of oxygen-dependent premature infants","volume":"56","author":"Montealegre-Pomar","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101176","DOI":"10.1016\/j.siny.2020.101176","article-title":"What is bronchopulmonary dysplasia and does caffeine prevent it?","volume":"25","author":"Jensen","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"key":"B6","first-page":"569","article-title":"Reducing the incidence of chronic lung disease in very premature infants with aminophylline","volume":"5","author":"Armanian","year":"2014","journal-title":"Int J Prev Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2015.00012","article-title":"Drug therapy for the prevention and treatment of bronchopulmonary dysplasia","volume":"6","author":"Iyengar","year":"2015","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/164_2016_71","article-title":"Xanthines and phosphodiesterase inhibitors","volume":"237","author":"Spina","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s004670100650","article-title":"Treatment of severe theophylline toxicity with hemodialysis in a preterm neonate","volume":"16","author":"Gitomer","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"B10","first-page":"177","article-title":"Theophylline toxicity in Thai children","volume":"19","author":"Visitsunthorn","year":"2001","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B11","article-title":"Theophylline Toxicity. In","volume-title":"StatPearls [Internet]","author":"Journey","year":"2024"},{"key":"B12","first-page":"1","volume-title":"Evidence-Based Clinical Practice Guidelines for an Optimal Use of the Kangaroo Mother Method in Preterm and\/or Low Birth Weight Infants","author":"Ruiz-Pel\u00e1ez","year":"2007"},{"key":"B13","first-page":"1","volume-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica del Reci\u00e9n Nacido Prematuro. Sistema General de Seguridad Social en Salud-Colombia","author":"Cinets","year":"2013"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/nejmoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.siny.2007.09.008","article-title":"Adjunctive therapies in chronic lung disease: examining the evidence","volume":"13","author":"Tin","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD003214.pub3","article-title":"Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants","volume":"2016","author":"Ng","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B17","first-page":"1","volume-title":"Actualizaci\u00f3n de los lineamientos t\u00e9cnicos para la implementaci\u00f3n de Programas Madre Canguro en Colombia, con \u00e9nfasis en la nutrici\u00f3n del neonato prematuro o de bajo peso al nacer","author":"Charpak","year":"2017"},{"first-page":"349","volume-title":"STATA Power and Sample-Size Reference Manual","year":"2013","key":"B18"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamapediatrics.2016.4141","article-title":"Revisiting the definition of bronchopulmonary dysplasia effect of changing panoply of respiratory support for preterm neonates","volume":"171","author":"Isayama","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJM196702162760701","article-title":"Pulmonary disease following respirator therapy of hyaline-membrane disease","volume":"276","author":"Northway","year":"1967","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.14611","article-title":"Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: a systematic review. Meta-analysis, and metaregression","volume":"2","author":"Villamor-Martinez","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1055\/s-0038-1637761","article-title":"Bronchopulmonary dysplasia: can we agree on a definition?","volume":"35","author":"Bancalari","year":"2018","journal-title":"Am J Perinatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2017.00088","article-title":"Bronchopulmonary dysplasia: 50 years after the original description","volume":"4","author":"Bancalari","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The diagnosis of bronchopulmonary dysplasia in very preterm infants an evidence-based approach","volume":"200","author":"Jensen","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.7150\/ijbs.34211","article-title":"Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK\/NF-\u03baB and A2aR signaling in LPS-induced THP-1 macrophages","volume":"15","author":"Zhao","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1573396311666150113213352","article-title":"Clinical pharmacology of theophylline in preterm infants: effects, metabolism and pharmacokinetics","volume":"10","author":"Pacifici","year":"2014","journal-title":"Curr Pediatr Rev"},{"key":"B30","first-page":"2167","article-title":"Ameliorating effect of amiodarone versus propranolol in chronic theophylline toxicity in rats","volume":"13","author":"Matter","year":"2019","journal-title":"Eurasia J Biosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clp.2019.02.011","article-title":"Drugs for the prevention and treatment of bronchopulmonary dysplasia","volume":"46","author":"Mandell","year":"2019","journal-title":"Clin Perinatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3109\/14767058.2014.885941","article-title":"Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants","volume":"27","author":"Taha","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40272-020-00404-4","article-title":"Caffeine for the treatment of apnea in the neonatal intensive care unit: a systematic overview of meta-analyses","volume":"22","author":"Alhersh","year":"2020","journal-title":"Pediatr Drugs"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3346\/jkms.2015.30.12.1828","article-title":"Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis","volume":"30","author":"Park","year":"2015","journal-title":"J Korean Med Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-14-235","article-title":"The role of nutrition in promoting growth in pre-term infants with bronchopulmonary dysplasia: a prospective non-randomised interventional cohort study","volume":"14","author":"Gianni","year":"2014","journal-title":"BMC Pediatr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2019.00224","article-title":"Mother\u2019s own milk and bronchopulmonary dysplasia: a systematic review and meta-analysis","volume":"7","author":"Villamor-Mart\u00ednez","year":"2019","journal-title":"Front Pediatr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2022-011192","article-title":"Follow- up of Kangaroo mother care programmes in the last 28 years\u202f: results from a cohort of 57,154 low- birth-weight infants in Colombia","volume":"8","author":"Charpak","year":"2023","journal-title":"BMJ Glob Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1344291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:08:13Z","timestamp":1724130493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1344291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":37,"alternative-id":["10.3389\/fped.2024.1344291"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1344291","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"article-number":"1344291"}}